- Home
- MYO
MYO
Myomo Inc.
as 10-22-2024 4:00pm EST
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 121.5M | IPO Year: | 2017 |
| Target Price: | $7.63 | AVG Volume (30 days): | 106.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.06 - $5.64 | Next Earning Date: | 11-05-2024 |
| Revenue: | $21,111,062 | Revenue Growth: | 21.22% |
| Revenue Growth (this year): | 53.19% | Revenue Growth (next year): | 39.01% |
Stock Insider Trading Activity of Myomo Inc. (MYO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kovelman Harry | MYO | Chief Medical Officer | Sep 5 '24 | Sell | $3.76 | 6,700 | $25,182.62 | 123,556 | |
| Kovelman Harry | MYO | Chief Medical Officer | Sep 3 '24 | Sell | $4.01 | 2,029 | $8,140.35 | 123,556 |
Latest Myomo Inc. News
MYO Breaking Stock News: Dive into MYO Ticker-Specific Updates for Smart Investing
GuruFocus.com
5 days ago
Rosalind Advisors, Inc. Expands Stake in Myomo Inc
GuruFocus.com
14 days ago
Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ...
Business Wire
14 days ago
Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit
Business Wire
a month ago
Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly
Business Wire
2 months ago
Myomo to Participate in Two Investor Conferences in September
Business Wire
3 months ago
Myomo Reports Second Quarter 2024 Financial Results
MT Newswires
3 months ago
Craig-Hallum Initiates Myomo at Buy With $7 Price Target
Business Wire
3 months ago
Myomo to Report Second Quarter Financial Results on August 6, 2024
Compare MYO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MYO Myomo Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.